Crinetics’ $500M offering; Boehringer inks deal with macrocycles biotech

Plus, news about Inhibikase, Bio-Thera, Richter, InnoCare and Scholar Rock:

Crinetics prices $500M offering: The San Diego biotech upsized the offering …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Myth Busting Today’s Most Common Nutrition Misconceptions

Lucienne Ide, MD, PhD, Founder and CEO of Rimidi Ansley Dalbo, founder of Diabetes – What to Know Whether it’s on TikTok, WhatsApp, Instagram or

January 31, 2024

Continuous Medicaid enrollment linked to lower risk of late-stage lymphoma diagnosis

Continuous enrollment in Medicaid was associated with a lower rate of a late-stage lymphoma diagnosis in children and adolescents/young adults (AYAs).

November 13, 2024

Are AI chatbots more creative than humans? New study reveals surprising results

The study published in Scientific Reports compared human and AI chatbot creativity using the alternate uses task (AUT), finding that AI chatbots generally outperformed humans

September 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.